Q/C Technologies, Inc. (QCLS)
Nasdaq: QCLS · In Vitro & In Vivo Diagnostic Substances · New York, NY · filing with the SEC since 2005
Filings
407 filings since 2017 beside 103 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Oct 20, 2025.
Filings a yearinsider forms included
4990742946455228
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 11 times in the last 36 months, the newest Sep 18, 2026.Auditor change (8-K item 4.01): 2 times in the last 36 months, the newest Mar 13, 2026.Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Mar 21, 2025.SEC letters: 11 in the last 36 months, the newest Feb 12, 2026.A late-filing notice, Form NT 10-K, filed Mar 31, 2026.A late-filing notice, Form NT 10-Q, filed Nov 14, 2025.A late-filing notice, Form NT 10-Q, filed Aug 14, 2025.A late-filing notice, Form NT 10-K, filed Mar 31, 2025.A late-filing notice, Form NT 10-Q, filed Aug 14, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 18, 2026
8-K items 1.01, 5.02, 7.01, 9.01
Major agreement signed; Officer or director change; Investor disclosure (Regulation FD) · Current report
Sep 14, 2026
Sep 11, 2026
8-K items 1.02, 5.02, 9.01
Major agreement ended; Officer or director change · Current report
Sep 10, 2026
Jan 23, 2026
8-K items 1.01, 5.02, 8.01, 9.01
Major agreement signed; Officer or director change; Other event · Current report
Jan 16, 2026
Dec 9, 2025
8-K items 1.01, 3.02, 8.01, 9.01
Major agreement signed; Shares sold without registration; Other event · Current report
Dec 8, 2025
Nov 14, 2025
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
Oct 3, 2025
8-K items 1.01, 3.02, 3.03, 5.02, 9.01
Major agreement signed; Shares sold without registration; Change to shareholders' rights; Officer or director change · Current report
Sep 30, 2025
Sep 26, 2025
8-K items 5.03, 7.01, 9.01
Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Sep 22, 2025
Sep 10, 2025
8-K items 1.01, 3.03, 5.03, 7.01, 9.01
Major agreement signed; Change to shareholders' rights; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Sep 4, 2025
Sep 2, 2025
8-K items 1.01, 1.02, 3.02, 3.03, 5.02, 5.03, 7.01, 9.01
Major agreement signed; Major agreement ended; Shares sold without registration; Change to shareholders' rights; Officer or director change; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Aug 28, 2025
Jun 6, 2025
8-K items 3.03, 5.03, 5.07, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change; Shareholder vote · Current report
Jun 3, 2025
40 of 407 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.